Enzymatica has signed agreements with the pharmacy chain Pharma+ and the wellness chain Matas in Denmark to sell ColdZyme.
From November this year, ColdZyme will be available on the Danish market, and thus in all of Scandinavia.
“According to plan, we are expanding to our neighboring countries using our own sales organization, building a platform of close relationships with the pharmacy and wellness market throughout Scandinavia. The expanded geographic presence sets the scene for continued growth and further geographic expansion. A strong domestic market position supports successful international distribution later on”, says Christian W. Jansson, CEO, Enzymatica.
ColdZyme will be sold in Denmark through Pharma+, one of the dominant chains with pharmacies in metropolitan areas, as well as through the wellness chain Matas’ approximately 300 stores throughout Denmark. In a similar way as in Sweden and Norway, the pharmacies will be trained and supported by Enzymatica’s own local sales organization. The product launch will begin in late October and continue throughout the cold season.
The ColdZyme mouth spray has been on sale via pharmacies and health specialist stores in Sweden since 2013. In 2014 the product expanded to pharmacies in Norway and the Boots pharmacy chain in the UK.
